UNSPSC 51181611: Azetirelin

This classification denotes a thyrotropin-releasing hormone analogue with the molecular formula C15H20N6O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 70J5AWG54Q, chemically known as l-prolinamide, n-((4-oxo-2-azetidinyl)carbonyl)-l-histidyl-, (s)- but generally known as azetirelin, which bears US NIH Compound Identifier 65841. Azetirelin most often comes in base and dihydrate forms. European Medicines Agency schedules Azetirelin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05653MIG.

UNSPSC 51181611 Azetirelin is a Commodity code identifying a specific pharmaceutical agent, but state and local procurement activity under this code is not evident in recent solicitation records. The code's specificity — naming a single active pharmaceutical ingredient rather than a broader drug class or therapeutic category — limits its application to state and local purchasing to specialized medical procurement contexts such as state health departments, correctional facilities, or public health programs that stock or dispense this agent. No recent state or local contract opportunities tagged to this code appear in available records, making it impossible to characterize issuing-body patterns, geographic concentration, or representative solicitations.

Without visible recent activity, pursuit of opportunities under UNSPSC 51181611 is not actionable at this time. Monitor state health department and correctional-system procurement channels if your firm supplies azetirelin or pharmaceutical procurement services; the code may see sporadic, episodic demand rather than continuous solicitation activity.